LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

LLY

1,104.03

+0.68%↑

JNJ

231.1

+1.28%↑

ABBV

229.8

+6.05%↑

UNH

406.18

+1.48%↑

NVS

148.46

+1.12%↑

Search

Medpace Holdings Inc

Closed

SectorHealthcare

454.5 -0.85

Overview

Share price change

24h

Current

Min

443.66

Max

461.84

Key metrics

By Trading Economics

Income

-11M

124M

Sales

-1.8M

707M

P/E

Sector Avg

29.031

49.712

EPS

4.28

Profit margin

17.53

Employees

6,300

EBITDA

-9.5M

154M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-1.73% downside

Dividends

By Acuity

Next Earnings

22 Jul 2026

Market Stats

By TradingEconomics

Market Cap

-1.9B

13B

Previous open

455.35

Previous close

454.5

News Sentiment

By Acuity

19%

81%

28 / 342 Healthcare

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat